T
Tiziana Zaro
Publications - 4
Citations - 1253
Tiziana Zaro is an academic researcher. The author has contributed to research in topics: Bivalirudin & Acute coronary syndrome. The author has an hindex of 3, co-authored 4 publications receiving 1000 citations.
Papers
More filters
Journal ArticleDOI
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial
Marco Valgimigli,Andrea Gagnor,Paolo Calabrò,Enrico Frigoli,Sergio Leonardi,Tiziana Zaro,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Alessandra Repetto,Ugo Limbruno,Bernardo Cortese,Paolo Sganzerla,Alessandro Lupi,Mario Galli,Salvatore Colangelo,Salvatore Ierna,Arturo Ausiello,Patrizia Presbitero,Gennaro Sardella,Ferdinando Varbella,Giovanni Esposito,Andrea Santarelli,Simone Tresoldi,Marco Stefano Nazzaro,Antonio Zingarelli,Nicoletta De Cesare,Stefano Rigattieri,Paolo Tosi,Cataldo Palmieri,Salvatore Brugaletta,Sunil V. Rao,Dik Heg,Martina Rothenbühler,Pascal Vranckx,Peter Jüni +35 more
TL;DR: In patients with acute coronary syndrome undergoing invasive management, radial as compared with femoral access reduces net adverse clinical events, through a reduction in major bleeding and all-cause mortality.
Journal ArticleDOI
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
Marco Valgimigli,Enrico Frigoli,Sergio Leonardi,Pascal Vranckx,Martina Rothenbühler,Matteo Tebaldi,Ferdinando Varbella,Paolo Calabrò,Stefano Garducci,Paolo Rubartelli,Carlo Briguori,Giuseppe Andò,Maurizio Ferrario,Ugo Limbruno,Roberto Garbo,Paolo Sganzerla,Filippo Russo,Marco Stefano Nazzaro,Alessandro Lupi,Bernardo Cortese,Arturo Ausiello,Salvatore Ierna,Giovanni Esposito,Giuseppe Ferrante,Andrea Santarelli,Gennaro Sardella,Nicoletta De Cesare,Paolo Tosi,Arnoud W J van 't Hof,Elmir Omerovic,Salvatore Brugaletta,Stephan Windecker,Dik Heg,Peter Jüni,Gianluca Campo,Lucia Uguccioni,Corrado Tamburino,Patrizia Presbitero,Dennis Zavalloni-Parenti,Fabio Ferrari,Roberto Ceravolo,Fabio Tarantino,Giampaolo Pasquetto,Gavino Casu,Stefano Mameli,Maria Letizia Stochino,Pietro Mazzarotto,Alberto Cremonesi,Francesco Saia,Giovanni Saccone,Fabio Abate,Andrea Picchi,Roberto Violini,Salvatore Colangelo,Giacomo Boccuzzi,Vincenzo Guiducci,Carlo Vigna,Antonio Zingarelli,Andrea Gagnor,Tiziana Zaro,Simone Tresoldi,Pietro Vandoni,Marco Contarini,Armando Liso,Dellavalle A,Salvatore Curello,Fabio Mangiacapra,Rosario Evola,Cataldo Palmieri,Camillo Falcone,Francesco Liistro,Manuela Creaco,Antonio Colombo,Alaide Chieffo,Andrea Perkan,Stefano De Servi,Dionigi Fischetti,Stefano Rigattieri,Alessandro Sciahbasi,Edoardo Pucci,Enrico Romagnoli,Claudio Moretti,Luciano Moretti,Raffaele De Caterina,Marcello Caputo,Marco Zimmarino,Ezio Bramucci,Emilio Di Lorenzo,Maurizio Turturo,Roberto Bonmassari,Carlo Penzo,Bruno Loi,Ciro Mauro,Anna Sonia Petronio,Gabriele Gabrielli,Antonio Micari,Flavia Belloni,Francesco Amico,Marco Comeglio,Claudio Fresco,Isala Klinieken,Nicolas M. Van Mieghem,Roberto Diletti,Evelyn Regar,Manel Sabaté,José Francisco Díaz Fernández,Vicente Mainar,José M. de la Torre Hernández +107 more
TL;DR: The prespecified final 1-year outcomes of the MATRIX programme, designed to assess the comparative safety and effectiveness of radial versus femoral access and of bivalirudin versus unfractionated heparin with optional glycoprotein IIb/IIIa inhibitors in patients with the whole spectrum of acute coronary syndrome undergoing invasive management, are described.
Journal ArticleDOI
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome.
Giuseppe Gargiulo,Greta Carrara,Enrico Frigoli,Sergio Leonardi,Pascal Vranckx,Gianluca Campo,Ferdinando Varbella,Paolo Calabrò,Tiziana Zaro,Davide Bartolini,Carlo Briguori,Giuseppe Andò,Maurizio Ferrario,Ugo Limbruno,Salvatore Colangelo,Paolo Sganzerla,Filippo Russo,Marco Stefano Nazzaro,Giovanni Esposito,Giuseppe Ferrante,Andrea Santarelli,Gennaro Sardella,Stephan Windecker,Marco Valgimigli +23 more
TL;DR: In this paper, the authors evaluated efficacy and safety of a full or low post-PCI bivalirudin regimen in acute coronary syndrome (ACS) patients with or without ST-segment elevation.
Journal ArticleDOI
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial.
Antonio Landi,Mattia Branca,Giuseppe Andò,Filippo Russo,Enrico Frigoli,Giuseppe Gargiulo,Carlo Briguori,Pascal Vranckx,Sergio Leonardi,Felice Gragnano,Paolo Calabrò,Gianluca Campo,Giuseppe Ambrosio,Andrea Santucci,Ferdinando Varbella,Tiziana Zaro,Dik Heg,Stephan Windecker,Peter Jüni,Giovanni Pedrazzini,Marco Valgimigli +20 more
TL;DR: In the MATRIX-Antithrombin and Treatment Duration study, 128 patients were excluded due to incomplete information on serum creatinine (sCr) or end-stage renal disease on dialysis treatment.